{"id":"https://openalex.org/W2925864422","doi":"https://doi.org/10.1007/s00125-019-4856-7","title":"Efficacy and safety of evolocumab in individuals with type 2 diabetes mellitus: primary results of the randomised controlled BANTING study","display_name":"Efficacy and safety of evolocumab in individuals with type 2 diabetes mellitus: primary results of the randomised controlled BANTING study","alternate_titles":[],"publication_year":2019,"publication_date":"2019-04-05","ids":{"openalex":"https://openalex.org/W2925864422","doi":"https://doi.org/10.1007/s00125-019-4856-7","mag":"2925864422","pmid":"https://pubmed.ncbi.nlm.nih.gov/30953107","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6509076"},"language":"en","primary_location":{"id":"doi:10.1007/s00125-019-4856-7","doi":"https://doi.org/10.1007/s00125-019-4856-7","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s00125-019-4856-7","pdf_url":"https://link.springer.com/content/pdf/10.1007/s00125-019-4856-7.pdf","source":{"id":"https://openalex.org/S104375418","display_name":"Diabetologia","issn_l":"0012-186X","issn":["0012-186X","1432-0428"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetologia","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2925864422"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://link.springer.com/content/pdf/10.1007/s00125-019-4856-7.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5060465607","display_name":"Robert S. Rosenson","orcid":"https://orcid.org/0000-0002-5599-0633","observed_orcids":["https://orcid.org/0000-0002-5599-0633"]},"institutions":[{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Robert S. Rosenson","raw_affiliation_strings":["Icahn School of Medicine at Mount Sinai, 1425 Madison Ave, MC Level, New York, NY, 10029, USA. robert.rosenson@mssm.edu","Icahn School of Medicine at Mount Sinai, 1425 Madison Ave, MC Level, New York, NY, 10029, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Icahn School of Medicine at Mount Sinai, 1425 Madison Ave, MC Level, New York, NY, 10029, USA. robert.rosenson@mssm.edu","institution_ids":["https://openalex.org/I98704320"]},{"raw_affiliation_string":"Icahn School of Medicine at Mount Sinai, 1425 Madison Ave, MC Level, New York, NY, 10029, USA","institution_ids":["https://openalex.org/I98704320"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085888091","display_name":"Martha L. Daviglus","orcid":"https://orcid.org/0000-0002-6791-8727","observed_orcids":["https://orcid.org/0000-0002-6791-8727"]},"institutions":[{"id":"https://openalex.org/I39422238","display_name":"University of Illinois Chicago","ror":"https://ror.org/02mpq6x41","country_code":"US","type":"education","lineage":["https://openalex.org/I39422238"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Martha L. Daviglus","raw_affiliation_strings":["University of Illinois at Chicago College of Medicine, Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Illinois at Chicago College of Medicine, Chicago, IL, USA","institution_ids":["https://openalex.org/I39422238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037652425","display_name":"Yehuda Handelsman","orcid":"https://orcid.org/0000-0001-7830-0247","observed_orcids":["https://orcid.org/0000-0001-7830-0247"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yehuda Handelsman","raw_affiliation_strings":["Metabolic Institute of America, Tarzana, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Metabolic Institute of America, Tarzana, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087265840","display_name":"Paolo Pozzilli","orcid":"https://orcid.org/0000-0001-5090-636X","observed_orcids":["https://orcid.org/0000-0001-5090-636X"]},"institutions":[{"id":"https://openalex.org/I155125353","display_name":"Universit\u00e0 Campus Bio-Medico","ror":"https://ror.org/04gqx4x78","country_code":"IT","type":"education","lineage":["https://openalex.org/I155125353"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Paolo Pozzilli","raw_affiliation_strings":["University Campus Bio-medico, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Campus Bio-medico, Rome, Italy","institution_ids":["https://openalex.org/I155125353"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053191013","display_name":"Harold Edward Bays","orcid":"https://orcid.org/0000-0001-9912-1408","observed_orcids":["https://orcid.org/0000-0001-9912-1408"]},"institutions":[{"id":"https://openalex.org/I4210132010","display_name":"Louisville Metabolic and Atherosclerosis Research Center","ror":"https://ror.org/030y83r80","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210132010"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Harold Bays","raw_affiliation_strings":["Louisville Metabolic and Atherosclerosis Research Center, Louisville, KY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Louisville Metabolic and Atherosclerosis Research Center, Louisville, KY, USA","institution_ids":["https://openalex.org/I4210132010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052274869","display_name":"Maria Laura Monsalvo","orcid":"https://orcid.org/0000-0002-4113-9418","observed_orcids":["https://orcid.org/0000-0002-4113-9418"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Maria Laura Monsalvo","raw_affiliation_strings":["Amgen Inc., Thousand Oaks, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc., Thousand Oaks, CA, USA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089754626","display_name":"Mary Elliott\u2010Davey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117596","display_name":"Amgen (United Kingdom)","ror":"https://ror.org/02gvvc992","country_code":"GB","type":"company","lineage":["https://openalex.org/I1320553840","https://openalex.org/I4210117596"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mary Elliott-Davey","raw_affiliation_strings":["Amgen Ltd, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Ltd, Cambridge, UK","institution_ids":["https://openalex.org/I4210117596"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025538949","display_name":"Ransi M. Somaratne","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ransi Somaratne","raw_affiliation_strings":["Amgen Inc., Thousand Oaks, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc., Thousand Oaks, CA, USA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5007571294","display_name":"Peter D. Reaven","orcid":"https://orcid.org/0000-0001-8923-6690","observed_orcids":["https://orcid.org/0000-0001-8923-6690"]},"institutions":[{"id":"https://openalex.org/I4210113157","display_name":"Phoenix VA Health Care System","ror":"https://ror.org/024b7e967","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210113157","https://openalex.org/I4210138663"]},{"id":"https://openalex.org/I4405259572","display_name":"University of Arizona College of Medicine- Phoenix","ror":"https://ror.org/02drhvq25","country_code":"US","type":"education","lineage":["https://openalex.org/I138006243","https://openalex.org/I4405259572"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Peter Reaven","raw_affiliation_strings":["University of Arizona College of Medicine, Phoenix VA Health Care System, Phoenix, AZ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Arizona College of Medicine, Phoenix VA Health Care System, Phoenix, AZ, USA","institution_ids":["https://openalex.org/I4210113157","https://openalex.org/I4405259572"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":8,"corresponding_author_ids":["https://openalex.org/A5060465607"],"corresponding_institution_ids":["https://openalex.org/I98704320"],"apc_list":{"value":4390,"currency":"USD","value_usd":4390},"apc_paid":{"value":4390,"currency":"USD","value_usd":4390},"fwci":5.0496,"has_fulltext":true,"cited_by_count":84,"citation_normalized_percentile":{"value":0.96450238,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":92,"max":99},"biblio":{"volume":"62","issue":"6","first_page":"948","last_page":"958"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/evolocumab","display_name":"evolocumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/pcsk9-inhibitors","display_name":"PCSK9 inhibitors","score":0.8320000171661377},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9829999804496765},{"id":"https://openalex.org/keywords/hypercholesterolemia","display_name":"hypercholesterolemia","score":0.9580000042915344},{"id":"https://openalex.org/keywords/mixed-dyslipidemia","display_name":"mixed dyslipidemia","score":0.9210000038146973},{"id":"https://openalex.org/keywords/ldl-cholesterol-lowering","display_name":"LDL cholesterol lowering","score":0.7960000038146973},{"id":"https://openalex.org/keywords/statin-intolerance","display_name":"statin intolerance","score":0.6050000190734863},{"id":"https://openalex.org/keywords/non-hdl-cholesterol","display_name":"non-HDL cholesterol","score":0.7450000047683716},{"id":"https://openalex.org/keywords/triglycerides","display_name":"triglycerides","score":0.6600000262260437},{"id":"https://openalex.org/keywords/lipoproteins","display_name":"lipoproteins","score":0.6380000114440918},{"id":"https://openalex.org/keywords/mixed-meal-tolerance-test","display_name":"mixed meal tolerance test","score":0.8080000281333923},{"id":"https://openalex.org/keywords/postprandial-lipemia","display_name":"postprandial lipemia","score":0.7580000162124634},{"id":"https://openalex.org/keywords/glucose-metabolism","display_name":"glucose metabolism","score":0.45899999141693115},{"id":"https://openalex.org/keywords/inflammatory-markers","display_name":"inflammatory markers","score":0.8100000023841858},{"id":"https://openalex.org/keywords/cardiovascular-risk-reduction","display_name":"cardiovascular risk reduction","score":0.5690000057220459},{"id":"https://openalex.org/keywords/banting","display_name":"Banting","score":0.8119999766349792}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8391802310943604},{"id":"https://openalex.org/C2778114629","wikidata":"https://www.wikidata.org/wiki/Q15623825","display_name":"Evolocumab","level":5,"score":0.7870818376541138},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.6544652581214905},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6311683654785156},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5952014327049255},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5777694582939148},{"id":"https://openalex.org/C2776839432","wikidata":"https://www.wikidata.org/wiki/Q954845","display_name":"Statin","level":2,"score":0.48960429430007935},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.4597383737564087},{"id":"https://openalex.org/C2780948078","wikidata":"https://www.wikidata.org/wiki/Q21130010","display_name":"PCSK9","level":5,"score":0.4515326917171478},{"id":"https://openalex.org/C2778848681","wikidata":"https://www.wikidata.org/wiki/Q6725716","display_name":"Macrovascular disease","level":4,"score":0.42024126648902893},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.40649956464767456},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.3918222188949585},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.30382341146469116},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.26019957661628723},{"id":"https://openalex.org/C2780072125","wikidata":"https://www.wikidata.org/wiki/Q28350","display_name":"Lipoprotein","level":3,"score":0.19997161626815796},{"id":"https://openalex.org/C2780745583","wikidata":"https://www.wikidata.org/wiki/Q1316030","display_name":"Apolipoprotein A1","level":4,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C43554185","wikidata":"https://www.wikidata.org/wiki/Q425649","display_name":"LDL receptor","level":4,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000924","descriptor_name":"Anticholesteremic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006937","descriptor_name":"Hypercholesterolemia","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D006937","descriptor_name":"Hypercholesterolemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008078","descriptor_name":"Cholesterol, LDL","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1007/s00125-019-4856-7","doi":"https://doi.org/10.1007/s00125-019-4856-7","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s00125-019-4856-7","pdf_url":"https://link.springer.com/content/pdf/10.1007/s00125-019-4856-7.pdf","source":{"id":"https://openalex.org/S104375418","display_name":"Diabetologia","issn_l":"0012-186X","issn":["0012-186X","1432-0428"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetologia","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:5504642","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6509076","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:6509076","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6509076/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetologia","raw_type":"Text"},{"id":"pmid:30953107","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30953107","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetologia","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1007/s00125-019-4856-7","doi":"https://doi.org/10.1007/s00125-019-4856-7","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s00125-019-4856-7","pdf_url":"https://link.springer.com/content/pdf/10.1007/s00125-019-4856-7.pdf","source":{"id":"https://openalex.org/S104375418","display_name":"Diabetologia","issn_l":"0012-186X","issn":["0012-186X","1432-0428"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetologia","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"},{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"},{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320308573","display_name":"Gilead Sciences","ror":"https://ror.org/056546b03"},{"id":"https://openalex.org/F4320309056","display_name":"Alnylam Pharmaceuticals","ror":"https://ror.org/00thr3w71"},{"id":"https://openalex.org/F4320310096","display_name":"Alere","ror":"https://ror.org/01zt0tq34"},{"id":"https://openalex.org/F4320311600","display_name":"Regeneron Pharmaceuticals","ror":"https://ror.org/02f51rf24"},{"id":"https://openalex.org/F4320314793","display_name":"Intarcia Therapeutics","ror":"https://ror.org/00s0pgz81"},{"id":"https://openalex.org/F4320315027","display_name":"Amarin Corporation","ror":"https://ror.org/02fccce66"},{"id":"https://openalex.org/F4320315666","display_name":"Medicines Company","ror":null},{"id":"https://openalex.org/F4320316238","display_name":"Kowa Company","ror":"https://ror.org/009z2z347"},{"id":"https://openalex.org/F4320322148","display_name":"Eisai","ror":"https://ror.org/04vvh7p27"},{"id":"https://openalex.org/F4320322436","display_name":"Novo Nordisk","ror":"https://ror.org/0435rc536"},{"id":"https://openalex.org/F4320329568","display_name":"Grifols","ror":"https://ror.org/02ed64f32"},{"id":"https://openalex.org/F4320331660","display_name":"Esperion Therapeutics","ror":"https://ror.org/019f2k932"},{"id":"https://openalex.org/F4320332585","display_name":"Allergan","ror":"https://ror.org/00wthd003"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2925864422.pdf","grobid_xml":"https://content.openalex.org/works/W2925864422.grobid-xml"},"referenced_works_count":22,"referenced_works":["https://openalex.org/W161816689","https://openalex.org/W1918902660","https://openalex.org/W2019071303","https://openalex.org/W2097870088","https://openalex.org/W2103647780","https://openalex.org/W2111232414","https://openalex.org/W2486690983","https://openalex.org/W2559592043","https://openalex.org/W2583862987","https://openalex.org/W2596179513","https://openalex.org/W2743957775","https://openalex.org/W2745511617","https://openalex.org/W2751210700","https://openalex.org/W2754562397","https://openalex.org/W2756174617","https://openalex.org/W2772281339","https://openalex.org/W2780743843","https://openalex.org/W2785715927","https://openalex.org/W2807324205","https://openalex.org/W2886129529","https://openalex.org/W4236673002","https://openalex.org/W4237834786"],"related_works":["https://openalex.org/W2809611706","https://openalex.org/W2921986630","https://openalex.org/W2918318471","https://openalex.org/W3106578052","https://openalex.org/W3158914372","https://openalex.org/W3120519358","https://openalex.org/W4321437559","https://openalex.org/W2809860024","https://openalex.org/W2155259933"],"abstract_inverted_index":{"AIMS/HYPOTHESIS:":[0],"The":[1],"study":[2,116,385],"aimed":[3],"to":[4,82,113,136,140,295],"examine":[5],"the":[6,105,114,124,141,233,271],"efficacy":[7],"of":[8,11,36,63,74,143,235,273,288,374],"12":[9,138,218,239,259,277],"weeks":[10,144,236,274],"monthly":[12],"evolocumab":[13,83,193,358],"or":[14,28,87,97,196,300,355],"placebo":[15,197],"in":[16,20,132,165,303,325,371],"lowering":[17],"LDL-cholesterol":[18],"(LDL-C)":[19],"individuals":[21,186,348],"with":[22,223,244,264,282,349],"type":[23,350],"2":[24,351],"diabetes":[25,52,352],"and":[26,31,56,121,139,146,157,167,174,179,189,228,238,266,276,291,332,341,353,362,377],"hypercholesterolaemia":[27,354],"mixed":[29,356],"dyslipidaemia":[30],"on":[32,47,338],"a":[33,59,301],"maximum-tolerated":[34,60],"statin":[35,61],"at":[37,64,216,232,257,270,406],"least":[38,65],"moderate":[39,66],"intensity.":[40,67],"METHODS:":[41],"<10%":[42],"(86":[43],"mmol/mol),":[44],"had":[45,335],"been":[46],"stable":[48],"pharmacological":[49],"therapy":[50],"for":[51,53],"\u22656":[54],"months":[55],"were":[57,79,128,187,313,369],"taking":[58],"dose":[62],"Lipid":[68],"eligibility":[69],"criteria":[70],"varied":[71],"by":[72,213,229,254,267,388],"history":[73],"clinical":[75,400],"cardiovascular":[76],"disease.":[77],"Participants":[78],"randomised":[80,188],"2:1":[81],"420":[84],"mg":[85],"s.c.":[86],"placebo.":[88],"Randomisation":[89],"was":[90,102,111,342,386],"performed":[91],"centrally":[92],"via":[93],"an":[94,308],"interactive":[95],"web-based":[96],"voice":[98],"recognition":[99],"system.":[100],"Allocation":[101],"concealed":[103],"using":[104],"centralised":[106],"randomisation":[107],"process.":[108],"Treatment":[109],"assignment":[110],"blinded":[112],"sponsor":[115],"team,":[117],"investigators,":[118],"site":[119],"staff":[120],"patients":[122],"throughout":[123],"study.":[125],"Co-primary":[126],"endpoints":[127,149],"mean":[129,142,234,272],"percentage":[130,163],"change":[131],"LDL-C":[133,151,154,212,297,304,361],"from":[134,398],"baseline":[135],"week":[137,217,258],"10":[145,237,275],"12.":[147],"Additional":[148],"included":[150,162],"<1.81":[152,298],"mmol/l,":[153],"reduction":[155,302],"\u226550%":[156],"other":[158,289],"lipids.":[159],"Exploratory":[160],"analyses":[161],"changes":[164,315,365],"fasting":[166],"post":[168,320],"mixed-meal":[169],"tolerance":[170],"test":[171],"(MMTT)":[172],"lipoproteins":[173],"lipids,":[175],"glucose":[176],"metabolism":[177],"variables":[178,340],"inflammatory":[180],"biomarkers.":[181],"RESULTS:":[182],"In":[183,346],"total,":[184],"421":[185],"analysed,":[190],"having":[191],"received":[192],"(280":[194],"participants)":[195,199],"(141":[198],"(mean":[200],"[SD]":[201],"age":[202],"62":[203],"[8]":[204],"years;":[205],"44%":[206],"women;":[207],"77%":[208],"white).":[209],"Evolocumab":[210,284,334],"decreased":[211,251],"54.3%":[214],"(1.4%)":[215],"(vs":[219,240,260,278],"1.1%":[220],"[1.9%]":[221],"decrease":[222,243,263,281],"placebo;":[224,245],"p":[225,246],"<":[226,247,317,367],"0.0001)":[227],"65.0%":[230],"(1.3%)":[231,256],"0.8%":[241],"[1.8%]":[242,262],"0.0001);":[248],"it":[249],"also":[250],"non-HDL-cholesterol":[252],"(HDL-C)":[253],"46.9%":[255],"0.6%":[261],"placebo)":[265],"56.6%":[268],"(1.2%)":[269],"0.1%":[279],"[1.6%]":[280],"placebo).":[283],"significantly":[285,359],"improved":[286],"levels":[287,305,373],"lipids":[290],"allowed":[292],"more":[293],"participants":[294],"reach":[296],"mmol/l":[299],"\u226550%.":[306],"After":[307],"MMTT":[309],"(120":[310],"min),":[311],"there":[312],"favourable":[314],"(p":[316,366],"0.05;":[318],"nominal,":[319],"hoc,":[321],"no":[322,336],"multiplicity":[323],"adjustment)":[324],"chylomicron":[326,329],"triacylglycerol":[327],"(triglycerides),":[328],"cholesterol,":[330],"VLDL-C":[331,376],"LDL-C.":[333,378],"effect":[337],"glycaemic":[339],"well":[343],"tolerated.":[344],"CONCLUSIONS/INTERPRETATION:":[345],"statin-treated":[347],"dyslipidaemia,":[357],"reduced":[360],"non-HDL-C.":[363],"Favourable":[364],"0.05)":[368],"observed":[370],"postprandial":[372],"chylomicrons,":[375],"TRIAL":[379],"REGISTRATION:":[380],"ClinicalTrials.gov":[381],"NCT02739984":[382],"FUNDING:":[383],"This":[384],"funded":[387],"Amgen":[389,399],"Inc.":[390],"DATA":[391],"AVAILABILITY:":[392],"Qualified":[393],"researchers":[394],"may":[395],"request":[396],"data":[397],"studies.":[401],"Complete":[402],"details":[403],"are":[404],"available":[405],"www.amgen.com/datasharing":[407],".":[408]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2925864422","counts_by_year":[{"year":2026,"cited_by_count":8},{"year":2025,"cited_by_count":14},{"year":2024,"cited_by_count":16},{"year":2023,"cited_by_count":15},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":14},{"year":2019,"cited_by_count":2}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2019-04-11T00:00:00"}
